ETRA: Parry Graham discloses securities transactions
By AlphaYouPublished Form 4
Parry Graham
Reporting filer
Parry Graham reported Conversion in Electra Therapeutics, Inc.: 85504 units of Common Stock, dated 2026-09-21. The full Form 4 contains 2 transaction entries.
- Disclosed
- Sep 21, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Parry Graham | 2026-09-21 | C | Conversion | 85504 | Not stated (see footnotes) | 85,504 | 0 days | Filed terms
|
| Series A Convertible Preferred Stock (derivative) | Parry Graham | 2026-09-21 | C | Conversion | 85504 | Not stated (see footnotes) | 0 | 0 days | Filed terms
|
Common Stock
- Owner
- Parry Graham
- Date
- 2026-09-21
- Code
- C
- Action
- Conversion
- Quantity
- 85504
- Price
- Not stated (see footnotes)
- Following holdings
- 85,504
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-21
- transaction Form Type: 4
- transaction Code: C
- equity Swap Involved: 0
- transaction Shares: 85504
- id: F1
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 85504
- direct Or Indirect Ownership: D
- nature Of Ownership:
Series A Convertible Preferred Stock (derivative)
- Owner
- Parry Graham
- Date
- 2026-09-21
- Code
- C
- Action
- Conversion
- Quantity
- 85504
- Price
- Not stated (see footnotes)
- Following holdings
- 0
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Series A Convertible Preferred Stock
- id: F2
- transaction Date: 2026-09-21
- transaction Form Type: 4
- transaction Code: C
- equity Swap Involved: 0
- transaction Shares: 85504
- id: F1
- id: F2
- transaction Acquired Disposed Code: D
- id: F2
- id: F2
- underlying Security Title: Common Stock
- underlying Security Shares: 85504
- id: F1
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Parry Graham: Chief Scientific Officer.
- F1: 7,125 of the shares ("Restricted Shares") shall be subject to vesting as follows: 1/4th of the Restricted Shares shall vest monthly commencing from September 2, 2026.
- F2: Each share of Series A Convertible Preferred Stock (the "Preferred Stock") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
Original sources
Prepared automatically from public filing data. Report a correction.